BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 28697793)

  • 1. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
    Yuan RX; Bao D; Zhang Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-30b-3p affects the migration and invasion function of ovarian cancer cells by targeting the CTHRC1 gene.
    Li Y; Zhou J; Wang J; Chen X; Zhu Y; Chen Y
    Biol Res; 2020 Mar; 53(1):10. PubMed ID: 32156314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.
    Chen G; Wang D; Zhao X; Cao J; Zhao Y; Wang F; Bai J; Luo D; Li L
    Cancer Cell Int; 2017; 17():118. PubMed ID: 29234238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-134 inhibits melanoma growth and metastasis by negatively regulating collagen triple helix repeat containing-1 (CTHRC1).
    Li Y; Fu Y; Gao Y; Li H; Ma L; Shu C; Li N; Ma C
    Int J Clin Exp Pathol; 2018; 11(9):4319-4330. PubMed ID: 31949828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer.
    Ma Z; Chao F; Wang S; Song Z; Zhuo Z; Zhang J; Xu G; Chen G
    Biochem Biophys Res Commun; 2020 Apr; 525(2):418-424. PubMed ID: 32102754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTHRC1 overexpression promotes ectopic endometrial stromal cell proliferation, migration and invasion via activation of the Wnt/β-catenin pathway.
    Lv Y; Zhang L; Ma J; Fei X; Xu K; Lin J
    Reprod Biomed Online; 2020 Jan; 40(1):26-32. PubMed ID: 31787549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.
    Cheng CW; Wang HW; Chang CW; Chu HW; Chen CY; Yu JC; Chao JI; Liu HF; Ding SL; Shen CY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1081-93. PubMed ID: 22476851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis.
    Sun LL; Cheng M; Xu XD
    World J Gastroenterol; 2019 Nov; 25(42):6311-6321. PubMed ID: 31754292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.
    Yu J; Feng J; Zhi X; Tang J; Li Z; Xu Y; Yang L; Hu Z; Xu Z
    Tumour Biol; 2015 May; 36(5):3221-9. PubMed ID: 25510669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1
    Liu J; Chen Z; Xiang J; Gu X
    Oncol Lett; 2018 Apr; 15(4):5561-5568. PubMed ID: 29556299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTHRC1 promotes human colorectal cancer cell proliferation and invasiveness by activating Wnt/PCP signaling.
    Yang XM; You HY; Li Q; Ma H; Wang YH; Zhang YL; Zhu L; Nie HZ; Qin WX; Zhang ZG; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12793-801. PubMed ID: 26722469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of CTHRC1 in proliferation, migration and invasion of human colorectal cancer cells].
    Yan L; Ye GT; Shen Z; Zhu X; Liu H; Li G
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):767-71, 776. PubMed ID: 26018280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-509-3p Suppresses Migration, Invasion, and Epithelial- Mesenchymal Transition in Melanoma Cells by Targeting Collagen Triple Helix Repeat Containing 1.
    Yuan K; Sun Y; Ji Y
    Balkan Med J; 2021 May; 38(3):177-182. PubMed ID: 33593721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
    Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
    Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.